Most people who take Ozempic for weight loss use it indefinitely. Medical guidelines now classify obesity as a chronic disease, similar to high blood pressure, and recommend continuing medication even after reaching your goal weight. There is no set time limit on how long you can take it, but stopping typically leads to significant weight regain within a year.
Ozempic vs. Wegovy: An Important Distinction
Ozempic is FDA-approved for type 2 diabetes, not weight loss. Its active ingredient, semaglutide, is the same drug found in Wegovy, which is approved specifically for chronic weight management at a higher dose (2.4 mg weekly versus Ozempic’s maximum of 2 mg). Many doctors prescribe Ozempic off-label for weight loss, but this distinction matters for insurance coverage, dosing, and how long your plan will authorize refills.
What Clinical Trials Show About Duration
The longest published trial of semaglutide for weight loss, known as STEP 5, followed participants for two full years (104 weeks). People in that study lost weight steadily and kept it off through the entire trial period, with no sign that the drug stopped working. At the 2.4 mg dose used for weight management, participants lost roughly 9.6% of their body weight over 68 weeks in trials involving people with type 2 diabetes, and results were even more pronounced in people without diabetes.
Gastrointestinal side effects like nausea, vomiting, and diarrhea were common, reported by about 82% of participants over two years compared to 54% on placebo. Most of these were mild to moderate and tended to ease over time, particularly during the initial dose increases.
What Happens When You Stop
This is the finding that shapes every conversation about duration. In an extension of the landmark STEP 1 trial, researchers followed participants for a full year after they stopped taking semaglutide. The results were striking: people regained about two-thirds of the weight they had lost. On average, that meant gaining back 11.6 percentage points of body weight within 12 months of stopping. The improvements in blood sugar, cholesterol, and blood pressure that came with the weight loss also reversed.
This pattern is consistent across GLP-1 medications. The American Diabetes Association’s 2026 standards of care note that sudden discontinuation of semaglutide or tirzepatide results in regain of one-half to two-thirds of lost weight within a year, along with worsening of the metabolic improvements the drugs provided.
Why Guidelines Recommend Long-Term Use
Because weight regain after stopping is so predictable, major medical organizations now recommend continuing obesity medications after reaching your target weight. The reasoning is straightforward: you wouldn’t stop taking blood pressure medication just because your numbers improved. The ADA guidelines state that “obesity pharmacotherapy indicated for chronic therapy should be continued beyond reaching weight loss goals to maintain the health benefits.”
That said, the guidelines also emphasize shared decision-making between you and your doctor. Some practical options include staying on the lowest effective dose for maintenance, trying intermittent therapy, or stopping the medication with close weight monitoring so you can restart if needed. Not everyone wants or can afford to stay on the drug permanently, and your doctor can help you weigh the tradeoffs.
Insurance Coverage and Renewal Requirements
If your insurer covers Ozempic for weight management (many still don’t, or require prior authorization), expect to meet renewal criteria. Kaiser Permanente’s policy offers a typical example: every 12 months, you need an updated weight and BMI on file, and you must have achieved and maintained at least 5% weight loss from your starting weight. Falling below that threshold could mean losing coverage.
Coverage policies vary widely between insurers, and some plans distinguish sharply between Ozempic (the diabetes formulation) and Wegovy (the weight loss formulation). If you’re using Ozempic off-label for weight loss, your insurer may not cover it at all, which can make long-term use a significant out-of-pocket expense.
Practical Considerations for Long-Term Use
If you and your doctor decide on ongoing treatment, a few things are worth knowing. The dose is gradually increased over the first several weeks to reduce nausea. Most people reach their maintenance dose within about four to five months. Weight loss typically continues for 12 to 18 months before plateauing, at which point the goal shifts from losing weight to keeping it off.
Some people find that a lower dose is sufficient for maintenance once they’ve reached their goal. This can reduce side effects and lower costs. Others need to stay at their full dose to prevent regain. There’s no universal answer, which is why regular check-ins with your prescriber matter more than following a fixed timeline. The two-year safety data from clinical trials is reassuring, and many patients are now well beyond that mark in real-world use, though longer-term data will continue to accumulate over the coming years.